Stilla Technologies: Funding, Investors & Team (Sep 2026)
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System. Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all Life Sciences areas: research, therapeutics, and all the “omics”.
Stilla Technologies has raised $54.9M across 2 funding rounds on record, the most recent a Debt Financing of $34.9M announced in Nov 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Stilla Technologies Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Stilla Technologies Funding Rounds
Stilla Technologies raised $20.0M in an undisclosed round announced in Feb 2020.
1.8 years later, a Debt Financing of $34.9M was announced in Nov 2021.
Stilla Technologies Founders and Leadership Team
No contact details are on record for this team yet.
Stilla Technologies Funding Compared to Other Biotechnology Startups
Stilla Technologies' latest round of $34.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Stilla Technologies in Biotechnology and Villejuif
Companies Similar to Stilla Technologies
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Stilla Technologies Funding FAQs
What does Stilla Technologies do?
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System. Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all Life Sciences areas: research, therapeutics, and all the “omics”.
How much funding has Stilla Technologies raised?
Stilla Technologies has raised $54.9M across 2 rounds on record. The most recent is a Debt Financing of $34.9M announced in Nov 2021.
When did Stilla Technologies last raise funding?
Stilla Technologies' most recent funding round on record is a Debt Financing of $34.9M, announced in Nov 2021.
Who is the CEO of Stilla Technologies?
Clement Gay is listed as CEO at Stilla Technologies.
Where is Stilla Technologies headquartered?
Stilla Technologies is based in Villejuif, Ile-De-France, France.
How many employees does Stilla Technologies have?
Stilla Technologies is in the 101-250 employee band.
How does Stilla Technologies' funding compare to other Biotechnology startups?
Stilla Technologies' latest round of $34.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Stilla Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Stilla Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.